Pseudallescheriasis: a summary of patients from 1980-2003 in a tertiary care center.
Arch Pathol Lab Med 2006;
130:1843-6. [PMID:
17149961 DOI:
10.5858/2006-130-1843-pasopf]
[Citation(s) in RCA: 15] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/25/2006] [Indexed: 11/06/2022]
Abstract
CONTEXT
Pseudallescheria boydii is being increasingly isolated in immunocompromised patients.
OBJECTIVE
To present 24 years of data on patients from whom P. boydii was isolated.
DESIGN
Retrospective review of archival laboratory data and patient charts at a tertiary care hospital with a full service mycology laboratory. All patients evaluated from whom P. boydii was isolated between 1980 and 2003 were included in this study.
RESULTS
Twenty-four patients from whom P. boydii had been isolated were identified. The majority of cases represented pulmonary involvement, particularly in cystic fibrosis patients. Three additional patients had infections in surgical or traumatic lesions of the head and 4 had disseminated disease. Invasive disease was associated with underlying malignancy or transplantation and resulted in death secondary to the fungal infection in the majority of cases.
CONCLUSIONS
Pseudallescheria boydii may cause significant disease in humans. Invasive infections with P. boydii are often misdiagnosed and inadequately treated. Aggressive treatment of locally invasive disease may be of value in preventing rapid and fatal dissemination with this organism.
Collapse